GSK PLC closed 19.70% below its 52-week high of £16.79, which the company achieved on September 9th.

The Swedish defense company posted better-than-expected earnings and [raised its annual sales guidance]( ...

Many people think that Warren Buffet is a good lead indicator for financial markets, and Berkshire Hathaway has been offloading US banks in recent months. Many people may ask why sell stocks when they ...

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

--In Europe, the Stoxx Europe 600 climbed 0.3% in morning trading. France's CAC 40 increased 0.4% and Germany's DAX rose 0.3%. Vestas Wind Systems added 11.6% after an upgrade. GSK lost over 6.0%, and ...

Arexvy is currently approved for use in all individuals aged 60 and older, as well as for high-risk individuals aged 50-59.

In the segment, while products like Nucala and Dovato are key top-line drivers, new long-acting HIV medicines, Cabenuva and ...

UK stocks have brushed off new tariff risks and the FTSE 100 is testing a new record closing high; Join the Markets Today ...

On Tuesday, Berenberg analysts downgraded GlaxoSmithKline (NYSE: GSK) stock from Buy to Hold, maintaining a price target of £16.00. The decision comes as GSK (LON: GSK)’s share price surged 25.94% ...